共 50 条
[1]
Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424
[2]
Ferlay J(2010)Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial Lancet Oncol 11 439-449
[3]
Soerjomataram I(2015)The role of the cancer center when using lymph node count as a quality measure for gastric cancer surgery JAMA Surg 150 37-43
[4]
Songun I(2015)Number of Lymph Nodes Removed and Survival after Gastric Cancer Resection: An Analysis from the US Gastric Cancer Collaborative J Am Coll Surg 221 291-299
[5]
Putter H(2014)Implications of inadequate lymph node staging in resectable gastric cancer: a contemporary analysis using the National Cancer Data Base Cancer 120 2855-2865
[6]
Kranenbarg EM-K(2009)The impact of N-ratio in minimizing stage migration phenomenon in gastric cancer patients with insufficient number or level of lymph node retrieved: results from a Chinese mono-institutional study in 2159 patients Ann Oncol 20 897-905
[7]
Morgan JW(2017)Re-evaluating the prognostic validity of the negative to positive lymph node ratio in node-positive gastric cancer patients Surgery 161 1588-1596
[8]
Ji L(2016)Prognostic value of three different lymph node staging systems in the survival of patients with gastric cancer following D2 lymphadenectomy Tumour Biol 37 11105-11113
[9]
Friedman G(2015)Prognostic performance of different lymph node staging systems after curative intent resection for gastric adenocarcinoma Ann Surg 262 991-998
[10]
Gholami S(2014)A comparison of five competing lymph node staging schemes in a cohort of resectable gastric cancer patients Ann Surg Oncol 21 875-882